ChatGPT or LLM in next-generation drug discovery and development: pharmaceutical and biotechnology companies can make use of the artificial intelligence-based device for a faster way of drug discovery and development

Affiliations

¹ School of Mechanical Engineering, Vellore Institute of Technology, Vellore, Tamil Nadu.
² Department of Zoology, Fakir Mohan University, Vyasa Vihar, Balasore, Odisha.
³ Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal, India.
⁴ Advanced Molecular Lab, Department of Microbiology, President Abdul Hamid Medical College, Karimganj, Kishoreganj.
⁵ Department of Microbiology, COVID-19 Diagnostic Lab, Noakhali Science and Technology University, Noakhali, Bangladesh.

Soumen Pal et al. Int J Surg. 2023.

. 2023 Dec 1;109(12):4382-4384.

doi: 10.1097/JS9.0000000000000719.

¹ School of Mechanical Engineering, Vellore Institute of Technology, Vellore, Tamil Nadu.
² Department of Zoology, Fakir Mohan University, Vyasa Vihar, Balasore, Odisha.
³ Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal, India.
⁴ Advanced Molecular Lab, Department of Microbiology, President Abdul Hamid Medical College, Karimganj, Kishoreganj.
⁵ Department of Microbiology, COVID-19 Diagnostic Lab, Noakhali Science and Technology University, Noakhali, Bangladesh.

No abstract available

Conflict of interest statement

All authors report no conflicts of interest relevant to this article.

1. Chopra H, Akash S, Chakraborty S, et al. . Artificial intelligence (AI) paving critical role in drug discovery, drug designing and studying drug-drug interactions - Correspondence. Int J Surg 2023. doi:10.1097/JS9.0000000000000564 Online ahead of print. - DOI - PMC - PubMed
1. Chakraborty C, Bhattacharya M, Dhama K, et al. . Artificial intelligence-enabled clinical trials might be a faster way to perform rapid clinical trials and counter future pandemics: lessons learned from the COVID-19 period. Int J Surg 2023;109:1535–1538. - PMC - PubMed
1. Malandraki-Miller S, Riley PR. Use of artificial intelligence to enhance phenotypic drug discovery. Drug Discov Today 2021;26:887–901. - PubMed
1. De Angelis L, Baglivo F, Arzilli G, et al. . ChatGPT and the rise of large language models: the new AI-driven infodemic threat in public health. Front Public Health 2023;11:1166120. - PMC - PubMed
1. Deng J, Lin Y. The benefits and challenges of ChatGPT: an overview. Front Comput Intell Syst 2022;2:81–83.